Company Information

Business Description

VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI’s first marketed product is Sci-B-Vac®, a hepatitis B (“HBV”) vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vac is approved for use in Israel and 14 other countries. VBI’s eVLP Platform technology allows for the development of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus (“CMV”) and glioblastoma multiforme (“GBM”). VBI is also advancing its LPV™ Thermostability Platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. VBI is headquartered in Cambridge, MA with research operations in Ottawa, Canada and research and manufacturing facilities in Rehovot, Israel. Learn more about VBI Vaccines >>

Corporate Presentation

IR Contacts

Investor Relations
Nell Beattie
Telephone: (617) 830-3031

U.S. Legal Counsel
Haynes Boone LLP
30 Rockefeller Plaza, 26th Floor
New York, NY 10112

Canadian Legal Counsel
Stikeman Elliott
5300 Commerce Court West
199 Bay Street
Toronto, Ontario M5L 1B9

EisnerAmper LLP
111 Wood Avenue South
Iselin, NJ 08830-2700
Telephone: (732) 243-7000

Transfer Agent
250 Royall Street
Canton, MA 02021
Telephone: (781) 575-2000

Industry Classifications


Vaccines Development

325414 Vaccines (i.e., bacterial, virus) manufacturing

2836 Biologics Products, except diagnostics substances

Frequently Asked Questions

What is VBI’s stock symbol?
Our stock is traded on the NASDAQ under the symbol VBIV.

Can I buy stock directly from VBI?
No, you will need to contact a licensed stock broker or use an online trading account.

How can I buy stock in VBI?
Through a licensed stock broker or by using an online trading account.

How do I change the address on my shareholder account?
Through your brokerage account or by contacting our transfer agent.

When was VBI incorporated?
Variation Biotechnologies Inc. was federally incorporated in Canada on August 24, 2001; Variation Biotechnologies (US), Inc.  was incorporated in Delaware on December 18, 2006.

Where is VBI located?
Our Corporate Headquarters is located in Cambridge, MA 02142, USA; our Research Operations are based in Ottawa, Ontario, Canada and we operate a Manufacturing Facility in Rehovot, Israel.

When is VBI’s fiscal year end?
December 31st.

Who is VBI’s transfer agent?
Computershare Limited.

Who are VBI’s independent auditors?
EisnerAmper LLP.

Who is VBI’s outside legal counsel?
Haynes Boone LLP.

Whom can I contact for general information about VBI?
Email us at